Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-29 @ 3:59 AM
Study NCT ID:
NCT07185269
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2025-09-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE
Sponsor:
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09-24
Start Date Type:
ACTUAL
Primary Completion Date:
2028-08-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11-04
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-09
First Submit QC Date:
None
Study First Post Date:
2025-09-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-25
Last Update Post Date:
2025-11-26
Last Update Post Date Type:
ESTIMATED